Restraint Regulatory & Promotional Restrictions Regulatory and promotional restrictions act as a significant restraint for the GLP-1 market because they prohibit surrogate marketing, such as disease awareness campaigns, ban direct-to-consumer advertising, and mandate strict prescriptions
If you have low blood potassium for a while, it may affect your kidneys
So, when coverage disappears, unfortunately, so do the progress and health benefits that were achieved
Food and Drug Administration (FDA): Has systems in place to monitor and track reports of negative events related to prescription medications, including GLP-1 receptor agonists like Ozempic, Wegovy, and other similar drugs
If people are falling for BS they find on social media, its not the fault of ozempic or the pharma industry
Clinical trials have shown it can help people lose up to 22.5% of their body weight